A novel strategy for efficient expression of an antibody fragment in Escherichia coli: ranibizumab as a case study - Priyanka - 2022 - Journal of Chemical Technology & Biotechnology - Wiley Online Library
Ranibizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Schematic structures of ranibizumab (A), bevacizumab (B), and... | Download Scientific Diagram
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats | Molecular Pharmaceutics
Emerging Treatments for Neovascular AMD - Retina Today
Avastin and Lucentis: Two Sides of the Same Coin?
_[Ranibizumab_Biosimilar_1].png "JAN: Japanese Accepted Names for Pharmaceuticals")
JAN: Japanese Accepted Names for Pharmaceuticals
Protein sequence optimization of anti-ranibizumab antibodies a, This... | Download Scientific Diagram
IMGt Protein displays of the VH and V-KAPPA domains of the bevacizumab... | Download Scientific Diagram
The multiple sequence alignment of known commercial antibodies s used... | Download Scientific Diagram
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study - ScienceDirect
A novel strategy for efficient expression of an antibody fragment in Escherichia coli: ranibizumab as a case study - Priyanka - 2022 - Journal of Chemical Technology & Biotechnology - Wiley Online Library
IJMS | Free Full-Text | Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
Full article: Ranibizumab in neovascular age-related macular degeneration
Ranibizumab biosimilar/polyethyleneglycol-conjugated gold nanoparticles as a novel drug delivery platform for age-related macular degeneration - ScienceDirect
12) Patent Application Publication (10) Pub. No.: US 2016/0289314 A1
Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A | Molecular Pharmaceutics
IJMS | Free Full-Text | Intravitreal Injection of Ranibizumab and CTGF shRNA Improves Retinal Gene Expression and Microvessel Ultrastructure in a Rodent Model of Diabetes
Ranibizumab Biosimilar, Research Grade, VEGF mAb - Ushelf
A Peek into the Diabetic Retinopathy Pipeline
Amino acid sequences of murine A4.6.1 and humanized A4.6.1 variants... | Download Scientific Diagram
Antiangiogenic therapy for ocular diseases: Current status and challenges - Chen - 2023 - MedComm – Future Medicine - Wiley Online Library
Ethanol as additive enhances expression of Ranibizumab in Escherichia coli: Impact on cellular physiology and transcriptome - ScienceDirect
